Late Wednesday, Watson Pharmaceuticals made it official that it was buying Actavis for $5.9 billion, creating a giant in the generic drug market.
Watson Pharmaceuticals is expected to bid as much as €5 billion ($6.6 billion) for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers. Read Post
Watson Pharmaceuticals agreed on Wednesday to buy the Swiss drug maker Actavis Group for up to 4.5 billion euros ($5.9 billion), as the American company looked to expand its presence in overseas markets. Read Post